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Thyroid destruction leading to endemic myxoedematous cre-
tinism is highly prevalent in central Africa, where iodine (I)
and selenium (SE) deficiencies as well as thiocyanate (SCN)
overload are combined. All three factors have been studied
experimentally in the etiology of the disease, but they have
never been studied in combination. In a model using rats, we
have previously shown that combining I and SE deficiencies
increases the sensitivity of the thyroid to necrosis after iodide
overload, an event unlikely to occur in the African situation.
To develop a model that would more closely fit with the epi-
demiological findings, we have determined whether an SCN
overload would also result in thyroid necrosis as does the I
overload. The combination of the three factors increased by
3.5 times the amount of necrotic cells, from 5.5  0.3% in the
ISE thyroids to 18.9  1.6% in the ISESCN-overloaded
ones. Methimazole administration prevented the SCN-in-
duced necrosis. SE thyroids evolved to fibrosis, whereas SE
thyroids did not. TGF was prominent in macrophages
present in SE glands. Thyroid destruction in central Africa
might therefore originate from the interaction of three fac-
tors: I and SE deficiencies by increasing H2O2 accumulation,
SE deficiency by decreasing cell defense and promoting fi-
brosis, and SCN overload by triggering follicular cell necrosis.
(Endocrinology 145: 994–1002, 2004)
ENDEMIC CRETINISM, the most severe manifestation ofiodine (I) deficiency, affects or has affected many en-
demic goiter areas around the world (1). However, the clin-
ical presentation of cretinism differs much between en-
demias, and the reasons for these clinical variations are not
yet clear. Quantitative differences in the severity of I defi-
ciency alone cannot account for the clinical variations of
cretinism (2).
The vast majority of cretins in central Africa are myx-
edematous, a feature that is not found in endemias where
neurological cretinism prevails (3, 4). Impaired thyroid func-
tion in the central African endemias is caused by progressive
destruction of the thyroid gland, a slow process affecting the
population on a large scale (5, 6). Thyroid damage impairs
the adaptive mechanisms to I deficiency (7, 8). Therefore,
people progressively tend to settle into hypothyroidism, and
when damage is severe enough, long-standing hypothyroid-
ism sets in, and myxedema develops. Finally, this may lead
to complete thyroid tissue atrophy, and some myxedematous
cretins no longer respond to I supplementation (5, 6). More-
over, the thyroids become fibrotic with time, and this is likely
to contribute to the destruction process (2). In the most severe
cases, thyroid damage starts in utero, and most of the damage
is believed to occur around birth and during the first years
of life (1).
The etiology of the elevated prevalence of thyroid destruc-
tion in African areas of endemic goiter is unknown. Factors
other than I deficiency are known to interfere with thyroid
metabolism. In this peculiar situation, people are exposed to
thiocyanate (SCN) overload caused by consumption of cas-
sava roots, which are used as a staple food and contain the
cyanogenic glucoside linamarin. Linamarin metabolism pro-
duces SCN, a well known goitrogen (9). SCN competes with
iodide (I) trapping as well as with I for its oxidation and I
binding to thyroglobulin at the level of the thyroperoxidase
enzyme (10, 11). Hence, SCN induces both a release of I from
the thyroid cell and a loss from the body. As a consequence,
SCN ultimately results in an I-deficient thyroid and a de-
crease in thyroid hormone synthesis. Experimental and ep-
idemiological studies have shown that SCN overload aggra-
vates the severity of I deficiency and worsens its outcomes
(12). However, the association of these two factors, i.e. SCN
overload and nutritional I deficiency, is not sufficient to
explain thyroid destruction in central Africa and hence the
elevated prevalence of myxedematous cretinism.
Selenium (SE) also interferes with thyroid function, and its
deficiency has been documented in central Africa (13–15).
Among the complex SE thyroid interactions (16–18), SE de-
ficiency has been implicated in the etiology of thyroid de-
struction and of myxedematous cretinism (13). SE is involved
in cell defense, e.g. as an active component of the family of
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glutathione peroxidase enzymes (19), selenoprotein P (20,
21), and thioredoxin reductase (22). Its deficiency favors cell
destruction in tissues exposed to free radical damage, in-
cluding tissues that synthesize large amounts of hydrogen
peroxide (H2O2). Such increased amounts of H2O2 are
present in the I-deficient thyroids as the result of their in-
creased TSH level (23) or by the lack of NADPH oxidase
inhibition by I (24). In agreement with this hypothesis, ex-
periments have repeatedly demonstrated increased necrosis
in various SE-deficient tissues exposed to free radical dam-
age (21, 25–27).
Experiments in rats have shown a high sensitivity of the
I- and SE-deficient thyroid gland to cell necrosis and suggest
a defective thyroid repair, through an impaired proliferation
of thyrocytes, and a fast evolution to fibrosis (25–27). In these
experiments both cell necrosis and the cascade of events
leading to thyroid fibrosis were dramatically increased when
necrosis was elicited by I overload. However, I supplemen-
tation in humans, even at a high dose, is evidently not in-
volved in the etiology of myxedematous cretinism in I-
deficient human endemias (28). Therefore, the experimental
association of only two environmental factors, i.e. severe I
deficiency combined with SE deficiency, would not be suf-
ficient to induce the considerable thyroid necrosis suggested
by the thyroid atrophy observed in central Africa. Never-
theless, the use of I overload to elicit thyroid necrosis in the
rat suggested that an SCN overload might have a similar and
yet unexplored effect on thyroid function. Indeed, SCN and
I share some common physicochemical properties (29) (i.e.
SCN is a pseudo-halide and has the same molecular volume
and comparable oxido-redox potential as I), and both are
oxidized by the peroxidase enzymes. It therefore appeared
important to test whether a SCN overload would also be
capable of triggering thyroid cell necrosis in I- and SE-defi-
cient glands. It is shown here that SCN triggers thyroid cell
necrosis in rats made deficient in both I and SE. It is also
shown that with this combination of the three environmental




Young female Wistar rats, 21 d old, weighing approximately 40 g at
the onset of the study, were used (four or five rats per group). They were
housed in a light- and temperature-controlled room and had free access
to food and water. They were fed either a semisynthetic diet containing
0.005 mg SE/kg with Torula yeast as protein source (SE groups; Hope
Farms, Woerden, The Netherlands) or the diet supplemented with 0.180
mg SE/kg (SE groups). The diets contained 0.380 mg I/kg.
Because of the difficulty in obtaining an SE-deficient diet that is also
I deficient, depletion of the I content of the thyroid was induced by
giving 1% sodium perchlorate in tap water [goitrous (I) rats], while
control (I) rats received tap water only, as described in the previous
experiments showing the necrotic effects of an I overload (26, 27). Per-
chlorate is known to compete with I trapping by the thyroid, resulting
in severe thyroidal I deficiency and high TSH stimulation of the gland.
After 5 wk, perchlorate was withdrawn, as it would interfere with the
thyroidal uptake of the SCN or I overloads. Twelve hours after per-
chlorate weaning, ISE, ISE, ISE, or ISE groups of rats were
injected ip with 1 mg sodium I diluted in 0.5 ml saline.
Other ISE or ISE groups of rats were injected ip with 20 mg
sodium SCN (Na-SCN; Sigma-Aldrich, Bornem, Belgium) diluted in 0.5
ml saline. The same dose of SCN was injected again 24 and 48 h after
the first SCN injection. The SCN-treated groups of rats received 1% SCN
in tap water starting after the first ip injection. In addition, to test the
possible role of the thyroperoxidase (TPO) enzyme in the hypothesis of
SCN toxicity, TPO was blocked in ISE and ISE groups of rats by
adding 0.02% methimazole (MMI) to the water of the SCN-treated rats,
starting the evening before the SCN overload was administered.
The animals were killed, under Nembutal anesthesia, at different
times of the study. I-deficient rats (both SE and SE) were killed after
5 wk of perchlorate treatment, before the I or SCN overloads. Rats were
also killed 3 and 15 d after the acute I overload or the onset of the SCN
treatment.
As previously described (26), in each rat one lobe of the thyroid was
quickly removed and weighed. The lobe was cut into two pieces; the first
half-lobe was fixed in Bouin’s liquid, and the other half was frozen in
isopentane, cooled in liquid nitrogen. The rats were then submitted to
cardiac puncture; plasma was separated and stored at 20 C for bio-
chemical determinations. The rats were perfused through the heart for
1 min with saline and for 5 min with glutaraldehyde. The thyroids were
further processed for morphological and stereological analyses. Ali-
quots measurements and analyses were made in a blinded manner.
Morphological analysis and stereological analysis
The thyroid fragments after glutaraldehyde perfusion were im-
mersed for 1.5 h in a solution of 2.5% glutaraldehyde (Taab, Reading,
UK) in 0.1 m cacodylate buffer (Taab; pH 7.4), postfixed for 1 h in 1%
osmium tetroxide, dehydrated in alcohol solutions of increasing
strength, and embedded in LX112 resin (Ladd Research Industries, Bur-
lington, VT).
Sections (0.5 m) were cut from the center of each fragment and
stained with toluidine blue. They were used for counting the number of
necrotic thyroid cells (i.e. with pycnotic or karyolitic nuclei). Counting
was performed at a magnification of 400 on 100 follicles/section and
on 10 sections/experimental group. Results are expressed as the mean
percentage of necrotic cells  sd. The relative volumes of the glandular
components (epithelium, follicular lumen, connective tissue, and blood
vessels) were determined in each group by stereological methods pre-
viously described (26).
Immunohistochemical analysis
The immunohistochemical analysis was performed on frozen sections
in which endogenous peroxidase had been inhibited by treatment with
periodic acid (0.228%) for 45 sec. Two different antibodies were used as
first antibodies. A mouse antibody against rat macrophages and den-
dritic cells (MCA 275, Serotec, Abingdon, UK), and a rabbit anti TGF
antibody (AB-20-PB, R&D Systems, Abingdon, UK). The method fol-
lowed has been previously described (27). The thyroid sections were
incubated with the first antibody (MCA 275 for 1 h and anti-TGF
antibody for 12 h). For the anti-TGF antibody, the time of incubation
used was chosen to allow clear labeling of inflammatory cells without
background staining, as shown previously (27). Thereafter, the sections
were incubated for 1 h with a second immunoperoxidase-conjugated
antibody. Antibody binding was revealed using diaminobenzidine tet-
rachloride in the presence of H2O2.
Thyroid hormones, thiocyanate, and glutathione
peroxidase assays
Thyroid hormone determinations were made by chemiluminescence
with commercially available kits for T4 and T3 (Chiron Diagnostics,
Fernwald, Germany). Thyroid stimulation after perchlorate treatment
was assessed by RIA measurement of TSH (Amersham, Little Chalfont,
UK). Plasma glutathione peroxidase activity was measured with a com-
mercial kit (Ransel kit, Randox, Crumlin, UK) using cumene hydroper-
oxide as substrate. Serum SCN measurement was made by spectropho-
tometry, adapted on a Cobas Mira-S, with phenylenediamine replacing
benzidine (30).
Statistical analyses
Comparison of the means between the various groups was made by
one-way ANOVA after logarithmic transformation of data, or Kruskal-
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Wallis and Mann-Whitney nonparametric tests. Results are expressed as




Selenium deficiency decreased the mean plasma glutathi-
one peroxidase to the 1/10th of the value in the SE control
groups. The mean GPX was 1450  371 IU/liter in the SE
rats vs. 13749  778 IU/liter in the SE rats. No significant
differences in plasma GPX were observed between the var-
ious SE-deficient groups.
SCN administration
The median circulating SCN value was 5.7 mg/liter (95%
confidence interval, 5.2–7.3 mg/liter) in non-SCN-treated
rats. Treatment with SCN increased this concentration sig-
nificantly (P  0.01) to a median SCN value of 32.6 mg/liter
(20.9–86.6 mg/liter) in SE groups of rats and to 18.5
mg/liter (12.9–53.0 mg/liter) in SE groups of rats. Plasma
SCN showed highly variable individual values among SCN-
treated rats. These tended to be lower in SE rats compared
with SE rats (not significant).
I deficiency and thyroid stimulation after
perchlorate administration
The severe I deficiency that accompanies inhibition of thy-
roidal I trapping by perchlorate resulted in undetectable
circulating T4 and T3 (Table 1) and in the expected thyroid
stimulation, as evidenced by elevated plasma TSH (139 47
ng/ml in perchlorate-treated rats; 16 2 ng/ml in euthyroid
rats), and by goiter formation. One lobe of the thyroid
weighed 7.4  0.5 mg in the euthyroid (I) condition (Table
1) and 17.3  0.2 and 21.0  1.2 mg in the ISE and ISE
groups, respectively (P  0.05).
As described in previous experiments (25, 26) using the
same protocol, the stimulation of the thyroid observed in the
perchlorate-treated, I-deficient rats significantly increased
the amount of necrotic epithelial cells compared with that in
the euthyroid group (0.3% in the ISE euthyroid group
and 5.5  0.4% in the ISE hypothyroid group; P  0.01).
SE deficiency increased the percentage of necrotic epithelial
cells in the glands of hypothyroid rats (9.9  0.6% in the
hypothyroid SE-deficient (ISE) group; P  0.01; Fig. 1).
However, this was not associated with any modification of
the relative volume of the interstitium (Fig. 2).
SCN overload compared with I overload after 3 d
Three days after the onset of SCN treatment, mean
plasma T3 increased to 45 25 and 77 26 ng/dl in I
SE
and ISE rats, respectively; the increase was significant
(P  0.01) with respect to the concentrations observed
before SCN treatment in both groups, whereas T4 re-
mained undetectable. This increase is likely to be the con-
sequence of the withdrawal of perchlorate treatment just
before the onset of SCN overload. T3 was undetectable in
the ISE rats treated with MMI and SCN and 9 7 ng/dl
in the ISE rats receiving MMI and SCN. Three days after
SCN administration, one thyroid lobe weighed 20.6  1.7
and 25.0  6.3 mg in the ISE and ISE groups, re-
spectively (P  0.05 between ISE and ISE). In the
groups treated with SCN and MMI, one thyroid lobe
weighed 29.1  0.9 and 24.2  2.8 mg in the ISE and
ISE groups, respectively (P  NS between these
groups).
The acute I overload was also accompanied after 3 d by
increased plasma T3 concentrations, to 68  26 and 65  9
ng/dl for ISE and ISE groups, respectively. Circulating
T4 also increased to 3.4  1.2 and 3.2  0.5 g/dl, respec-
tively, in the same two groups (P  0.01 compared with
before I for T3 and T4, in both I
SE and ISE groups). One
thyroid lobe weighed 20.2  2.6 and 27.6  4.3 mg in the
ISE and ISE groups, respectively (P  0.01).
Cell necrosis
Three days after its onset, SCN treatment significantly
increased the proportion of necrotic follicular cells from 5.5
0.4% before SCN to 7.8  0.15% after SCN in the ISE
groups (P 0.001) and from 9.9 0.6% before SCN to 18.9
1.6% in the ISE group (P  0.001; Fig. 1).
Concomitant MMI administration significantly reduced
the SCN-induced necrosis to 4.0  0.2% in the ISE group
and 6.8 0.3% in the ISE group (P 0.01 compared with
values in groups not receiving MMI). These values after MMI
administration are in the same range as those in I-deficient
goitrous rats before SCN administration (Fig. 1).
Three days after acute I administration, necrotic cells were
9.0  0.5% in the ISE rats and 20.2  0.3% in the ISE
group (P  0.001; Fig. 1). The necrotic effects, assessed after
3 d of treatment, were multiplied by 2.4 by SCN and by
2.2 by I.
Inflammatory reaction
Thiocyanate administration for 3 d allowed some goiter
involution, compared with that of rats before perchlorate
withdrawal. The follicular lumina were slightly enlarged,
and they contained cell debris. (Fig. 3, A and B). In the SE
deficient rats, the colloid was much denser and necrotic cells
were more numerous in the epithelial layer (Fig. 3B). Apical
TABLE 1. T4 and T3 concentrations and weight of one thyroid
lobe
T4 (g/dl) T3 (ng/dl) Thyroid weight (mg)
ISE 3.0  0.5 72  22 7.9  1.1a
ISE 3.2  0.5 45  9 9.1  2.1a
ISE ND ND 17.3  0.2
ISE ND ND 21.0  1.2
ISE NaI, 3 d 3.4  1.2 68  26 20.2  2.6a
ISE NaI, 3 d 3.2  0.5 65  9 27.6  4.3a
ISE SCN, 3 d ND 45  25 20.6  1.7a
ISE SCN, 3 d ND 77  26 25.0  6.3a
ISE SCN MMI, 3 d ND ND 29.1  0.9
ISE SCN MMI, 3 d ND 9  7 24.2  2.8
ISE NaI, 15 d 2.4  0.3 32  3 12.4  1.8
ISE NaI, 15 d 2.0  0.5 33  4 12.03  0.81
ISE SCN, 15 d ND 35  18 15.1  7.3
ISE SCN, 15 d ND 39  10 15.6  2.0
ND, Nondetectable.
a P  0.05 (ANOVA analysis after logarithmic transformation).
996 Endocrinology, February 2004, 145(2):994–1002 Contempre´ et al. • Thiocyanate Overload and Thyroid Necrosis
 by on May 24, 2010 endo.endojournals.orgDownloaded from 
blebs were frequently observed, and they were often large
including damaged organelles (Fig. 3, C and D). This sug-
gests that the apical pole is the first site of lesion. The inter-
stitium was infiltrated by mononuclear cells. These mono-
nuclear cells were mainly macrophages immunostained with
MCA 275 monoclonal antibody. They were much more nu-
merous in the SE deficient rats (Fig. 4, A and B). In these SE
deficient rats, cells producing TGF were also frequently
observed in the thyroid interstitium (Fig. 4C). No labeling
was observed when replacing the first anti-TGF antibody
by PBS buffer (Fig. 4D).
Necrosis and fibrosis 15 d after the onset of SCN overload
At this time point, mean plasma T3 was 35  18 and 39 
10 ng/dl in the ISE and ISE groups, respectively. T4
remained undetectable in both groups. The mean weight of
one thyroid lobe was 15.1  7.3 and 15.6  2.0 mg in the
ISE and ISE groups, respectively (P  NS). Necrotic
follicular cells were still 4.0 0.4% and 12.3 1.1% in ISE
and ISE groups, respectively (Fig. 1). This last value in the
ISE group was significantly higher (P  0.01) than that in
this group in the I-deficient goitrous condition before SCN
FIG. 1. Mean percentages SD of necrotic cells in
SE-sufficient and SE-deficient rats. SCN was ad-
ministered for up to 15 d, whereas the I overload
was acute. a, P  0.05; b, P  0.01; c, P  0.001
(by ANOVA after logarithmic transformation).
FIG. 2. Mean (SD) percentage of the surface
occupied by the connective tissue in SE-sufficient
and SE-deficient rats. a, P 0.01; b, P 0.001 (by
ANOVA after logarithmic transformation).
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and was significantly higher (P 0.01) than the value in this
group 15 d after acute I administration.
At 15 d after acute I administration, plasma T3 levels were
32  3 and 33  4 ng/dl in the ISE and ISE groups of
rats; the corresponding plasma T4 values were 2.4  0.3 and
2.0  0.5 g/dl. The percentage of necrotic cells was 4.6 
0.3% in the ISE and 7.6  0.6% in the ISE thyroids.
After SCN treatment or I overload, the SE-deficient thy-
roids evolved to fibrosis, while thyroids of SE-supplemented
rats did not (Fig. 5). The relative volume of connective tissue
15 d after SCN was 18.0 1.1% and 32.1 1.7% in ISE and
ISE thyroids, respectively, compared with 17  1.2% in
control ISE thyroids. The relative volume of connective
tissue 15 d after the acute I overload was 18.7  1.5% and
28.5  3.5% in the ISE and ISE thyroids, respectively
(Fig. 2).
Discussion
The present experimental association of three environ-
mental factors: I and SE deficiencies plus SCN excess, rep-
resents a short-term nutritional combination akin to the
chronic nutritional situation in central Africa. Together, these
factors are sufficient to produce thyroid necrosis and pro-
gressive fibrosis. A similar chronic interaction of nutriments
may therefore explain the progressive thyroid destruction
and the elevated prevalence of myxedematous cretinism that
characterizes that area of the world. Thereby, it may also
explain some of the discrepancies that exist between the
various forms of endemic cretinism world-wide.
First, this observation is a new insight into the relationship
that exists between SCN and thyroid function. Indeed, the
results show that SCN may trigger thyroid cell necrosis if a
few conditions are satisfied. These conditions are 1) thyroid
stimulation, and 2) SCN oxidation. Although necrosis is
present if these two conditions are fulfilled, SE deficiency
markedly increases this necrosis.
FIG. 3. A and B, Semithin sections of thyroids from ISE (A,350)
and ISE (B, 350) rats receiving SCN overload for 3 d. In ISE
rats, the slightly enlarged follicular lumina contain cell debris. In
ISE rats, the colloid is dense. Necrotic cells are observed in the
epithelial layer (arrows). C and D, Ultrathin sections of thyroids from
ISE rats (C,8500; D,7700). Apical lesions are frequent with the
formation of blebs (C), sometimes including damaged organelles (D).
FIG. 4. Immunoperoxidase staining using MCA 275 antibody spe-
cific for rat macrophage (A and B) and anti-TGF antibody (C) on
frozen sections of thyroids from ISE (A) and ISE rats (B and C)
receiving SCN for 3 d (125). Macrophages are more numerous in
SE-deficient rats, in which TGF-producing cells are detected. No
labeling is observed when the first anti-TGF antibody was replaced
by PBS buffer (D).
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Thyroid stimulation
Indeed, the necrotic effects of I or SCN are only observed
in the experimental condition leading to intense thyroid
stimulation, namely in the I groups. According to the ep-
idemiological I/SCN ratio findings in the central African
endemics, i.e. a low I/SCN ratio is required for a significant
goitrogenic effect of SCN to be observed, I deficiency should
be the cause of high TSH and thyroidal stimulation. Starting
from a urinary I/SCN ratio of 7 g/mg corresponding to
normal populations, goiter appears when the ratio is 3,
whereas at a ratio of 2, TSH rises markedly, and cretinism
become prevalent (9, 10).
The restriction of the necrotic effect of SCN on the I-deficient
thyroids could be explained by the influence of thyroid status
on SCN metabolism. Indeed, as it occurs with I trapping, SCN
trapping by the thyroid cell is increased by TSH (31). The in-
trathyroidal metabolism of SCN also increases with TSH stim-
ulation, and SCN is rapidly oxidized by the TPO enzyme in the
presence of H2O2. Therefore, SCN does not accumulate in the
thyrocyte, and the thyroid/serum SCN ratio remains low (29,
31). Therefore, the high sensitivity of the I-deficient stimulated
thyroid to SCN may be explained by its increased trapping
accompanied by an increased metabolism into a toxic metab-
olite, as postulated below.
SCN has first to be oxidized by TPO, because MMI
administration to rats could block the SCN-
induced necrosis
This condition is not necessary for the goitrogenic effects
of SCN to occur (9). Therefore, it appears that an oxidized
metabolite of SCN, rather than SCN itself, is toxic for the
thyroid cell. It is likely that MMI blocking of the SCN-
induced necrotic effect was not the consequence of decreased
SCN trapping at the basal membrane level. Indeed, MMI
transport into the thyroid cell differs from the transport of I,
and MMI does not inhibit I trapping (32). Presumably, there-
fore, MMI does not inhibit SCN trapping.
The present description of a necrotic effect of SCN has to
be dissociated from its already known goitrogenic effect, i.e.
competition as a substrate with I for its trapping and for its
metabolism at the TPO level. As a goitrogen, SCN is a weaker
inhibitor of I trapping than perchlorate (33). Both goitrogens
were used in the present experiment. Perchlorate was used
first to induce thyroidal I deficiency and intense thyroid
stimulation. Its substitution with SCN could not sustain a
comparable level of I deficiency, and SCN administration
allowed a rise in plasma T3, goiter involution, and some
colloid accumulation.
Which SCN metabolite is toxic for the thyroid and why?
SCN metabolism in the thyroid produces at least sulfate (31,
34) and an ill-identified protein-bound sulfur. It is not known
whether one of these two end products interferes with thy-
roid cell regulation and might take part in the observed
necrotic effect. However, SCN metabolism has been studied
in other systems. From these studies, it is known that sialo-,
myelo-, lacto-, and thyroperoxidase enzymes (35) have sim-
ilar activities, and that hypothiocyanite (OSCN) is pro-
duced from the oxidation of SCN by peroxidase enzymes in
presence of H2O2 (36–38). OSCN
 is a potent bacteriostatic
agent that inhibits bacterial metabolism and growth (39),
although OSCN itself does not seem to be toxic for the
mammalian cell (40, 41).
However, in certain conditions, i.e. when H2O2 is in excess
compared with SCN or OSCN, further OSCN oxidation
produces cyanosulfurous acid (O2SCN) and cyanosulfuric
acid (O3SCN) (42). These oxidized forms of OSCN
 are in-
deed reported to be more bactericidal than OSCN, to be
toxic for the mammalian cell, and to be more toxic for the cell
than H2O2 alone (40). In this same condition of H2O2 in
excess, cyanide (CN) formation may also occur, which
might take part in the toxic effects of SCN metabolism (43).
The first step of SCN metabolism, the oxidation of SCN to
OSCN, appears to be rate limiting in the metabolism of SCN
(34). It requires the peroxidase enzyme and H2O2. However,
the peroxidase enzyme does not appear to be required for
further oxidation of OSCN to the toxic metabolites. One of
the end products of this SCN oxidation process is sulfate, and
sulfate is detected in the thyroid as the result of SCN me-
tabolism (31, 34). Together, these findings suggest that toxic
SCN metabolites may well occur in the thyroid (Fig. 6),
especially in the I-deficient stimulated thyroid gland, where
SCN trapping and metabolism are increased as is H2O2 syn-
thesis. Moreover, the production of toxic metabolites would
be concentrated at the apical membrane level or in the lumen,
where I and SCN are concentrated and H2O2 generated. This
could be related to the apical lesions as blebs.
SE deficiency in this experiment had two major effects. It
dramatically increased the SCN-induced necrosis and pro-
moted thyroid fibrosis. Indeed, necrotic cells were present in
twice the number in SE-deficient thyroids compared with
SE-supplemented glands regardless of whether necrosis was
induced by SCN or by I overload. The precise mechanism by
which SE deficiency increases tissue sensitivity to necrosis is
not known. The initial hypotheses speculated on the impor-
tance of the cytosolic GPX enzyme, the first selenoprotein
identified in mammals (19), in protecting cells against free
radical damage (13). Since then, the role of this GPX enzyme
has to be balanced considering the increasing number of
identified selenoproteins involved directly or indirectly in
FIG. 5. Semithin sections of thyroids from ISE (A,120; C,400)
and ISE (B, 120; D, 400) rats receiving SCN overload for 15 d.
In ISE rats, the gland is dissociated by an extensively developed
fibrous tissue made of collagen fibers and fibroblasts.
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cell defense in a increasingly complex system. Indeed, in
some experiments the restoration of SE protection against
free radical damage in the liver correlated to SE protein P
levels and not to GPX levels (27). The thyroid also could be
peculiarly sensitive to cytosolic GPX deficiency. Indeed, in
the thyroid, cytosolic GPX is alleged to play a particularly
important role by inhibiting protein iodination in the cytosol
(44).
An evolution to fibrosis of the SE-deficient thyroids has
been described in experiments in which SCN was not in-
FIG. 6. Goitrogenic and toxic effects of SCN at the thyroid level. In gray frame, Hypothesis of the production of toxic metabolites from SCN
and H2O2, leading to cell necrosis. O2SCN, cyanosulfurous acid; ThOxs, thyroid oxidases; O3SCN, cyanosulfuric acid.
FIG. 7. Hypothesis for the mechanism by which
an interaction between I and SE deficiencies and
SCN overload induces thyroid necrosis and pro-
motes thyroid fibrosis and, as a consequence,
myxedematous cretinism if these conditions are
met early in life.
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volved (26, 27). Therefore, the evolution to fibrosis is not
specific to toxic SCN effects, but, rather, is a characteristic of
SE deficiency itself. Indeed, the cascade of events leading to
fibrosis, which has been described in previous SE experi-
ments (27), has also been observed in the present SCN ex-
periment. In short, in SE deficiency these events are 1) an
increased inflammatory reaction in response to necrosis, and
2) the presence of TGF-producing macrophages. In I-treated
animals, the evolution of the thyroid to fibrosis was pre-
vented by the administration of antibodies against TGF
(27). Thus, the combination of the three nutritional factors, I
and SE deficiencies plus SCN overload, leads to an interac-
tion of these factors that induces inflammation and fibrosis.
The toxic effects of I followed acute administration,
whereas those of SCN were prolonged over 15 d. Neverthe-
less, both treatments had similar consequences.
As represented in Fig. 7, the following model is proposed
for the interaction between the combined I and SE deficien-
cies and the SCN overload. Together, these interactions lead
to thyroid destruction. 1) Iodine deficiency causes stimula-
tion of the gland, which is an essential condition for thyroid
destruction to occur in the present experimental model. This
stimulation leads to increased H2O2 synthesis by the thyroid
gland. 2) Cell necrosis itself is triggered by SCN metabolism
in the highly stimulated thyroid gland. In addition, because
of the goitrogenic effects of SCN per se, its administration
helps to sustain thyroid overstimulation, and this would
contribute to render the necrotic effect chronic. 3) Selenium
deficiency would initially increase the sensitivity of the thy-
roid gland to necrosis. Up until then, despite the amount of
necrosis, thyroid repair would probably be possible, as the
potential of the thyroid to proliferate is not impaired.
However, 4) a second effect of SE deficiency would be to
increase the inflammatory reaction that follows necrosis, a
process in which macrophages secrete an excess of TGF. An
excess of TGF would definitely jeopardize thyroid repair
and enhance fibrosis. This could lead to thyroid destruction
and irreversible hypothyroidism. As the nutritional combi-
nation herein described has been documented in central Af-
rica, the acute interaction described in our experimental
model could explain the chronic process leading to thyroid
atrophy and elevated prevalence of myxedematous cretin-
ism in this goiter endemia. As smoking greatly increases
serum SCN levels, this combination could also occur spo-
radically in areas where cassava is not a nutrient.
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